Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2023 Filed Jun 20, 2023 20:15 UTC |
Nordstrom Phyllis BEVP & CHRO
|
Tax withholdingCommon Stock | 4,655 | $9.63 | $44,827.65 |
DisclosureSEC source: 0001209191-23-038357 · doc4.xml · nonDerivative · entry 1 Nordstrom Phyllis B · CIK 0001879982 · EVP & CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,749 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on June 15, 2022. Read SEC document |
| May 31, 2023 Filed May 31, 2023 20:10 UTC |
Puthenveetil RejiEVP, Industrial Solutions
|
SaleCommon Stock | 18,434 | $8.00 | $147,449.88 |
DisclosureSEC source: 0001209191-23-033102 · doc4.xml · nonDerivative · entry 1 Puthenveetil Reji · CIK 0001826896 · EVP, Industrial Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,982 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.95 to $8.025, inclusive. The reporting person undertakes to provide to 3D Systems Corporation, any security holder of 3D Systems Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 of this Form 4. Read SEC document |
| May 26, 2023 Filed May 30, 2023 20:08 UTC |
GRAVES JEFFREY ADirector · President and CEO
|
Tax withholdingCommon Stock | 27,693 | $7.99 | $221,267.07 |
DisclosureSEC source: 0001209191-23-032861 · doc4.xml · nonDerivative · entry 1 GRAVES JEFFREY A · CIK 0001251036 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 770,494 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on May 26, 2020. Read SEC document |
| May 18, 2023 Filed May 18, 2023 20:11 UTC |
Clinton MalissiaDirector
|
SaleCommon Stock | 8,685 | $8.58 | $74,488.64 |
DisclosureSEC source: 0001209191-23-030608 · doc4.xml · nonDerivative · entry 2 Clinton Malissia · CIK 0001769602 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,785 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.56 to $8.595 inclusive. The reporting person undertakes to provide to 3D Systems Corporation, any security holder of 3D Systems Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 of this Form 4. Read SEC document |
| May 16, 2023 Filed May 18, 2023 20:21 UTC |
Tracy John JDirector
|
GrantCommon Stock | 18,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-030628 · doc4.xml · nonDerivative · entry 1 Tracy John J · CIK 0001376806 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,558 F1 · shares: Shares were awarded to the Reporting Person pursuant to the Issuer's 2015 Incentive Plan. Read SEC document |
| May 16, 2023 Filed May 18, 2023 20:19 UTC |
MOORE KEVIN SDirector
|
GrantCommon Stock | 18,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-030625 · doc4.xml · nonDerivative · entry 1 MOORE KEVIN S · CIK 0001105969 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,850 F1 · shares: Shares were awarded to the Reporting Person pursuant to the Issuer's 2015 Incentive Plan. Read SEC document |
| May 16, 2023 Filed May 18, 2023 20:20 UTC |
Padmanabhan VasantDirector
|
GrantCommon Stock | 18,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-030626 · doc4.xml · nonDerivative · entry 1 Padmanabhan Vasant · CIK 0001608997 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,031 F1 · shares: Shares were awarded to the Reporting Person pursuant to the Issuer's 2015 Incentive Plan. Read SEC document |
| May 16, 2023 Filed May 18, 2023 20:18 UTC |
MCCLURE CHARLES GDirector
|
GrantCommon Stock | 18,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-030624 · doc4.xml · nonDerivative · entry 1 MCCLURE CHARLES G · CIK 0001084247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,964 F1 · shares: Shares were awarded to the Reporting Person pursuant to the Issuer's 2015 Incentive Plan. Read SEC document |
| May 16, 2023 Filed May 18, 2023 20:15 UTC |
ERICKSON THOMAS WDirector
|
GrantCommon Stock | 18,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-030618 · doc4.xml · nonDerivative · entry 1 ERICKSON THOMAS W · CIK 0001120226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,294 F1 · shares: Shares were awarded to the Reporting Person pursuant to the Issuer's 2015 Incentive Plan. Read SEC document |
| May 16, 2023 Filed May 18, 2023 20:17 UTC |
KEVER JIM DDirector
|
GrantCommon Stock | 18,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-030620 · doc4.xml · nonDerivative · entry 1 KEVER JIM D · CIK 0001105965 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 422,766 F1 · shares: Shares were awarded to the Reporting Person pursuant to the Issuer's 2015 Incentive Plan. Read SEC document |
| May 16, 2023 Filed May 18, 2023 20:12 UTC |
Curran William EdwardDirector
|
GrantCommon Stock | 18,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-030611 · doc4.xml · nonDerivative · entry 1 Curran William Edward · CIK 0001424365 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,503 F1 · shares: Shares were awarded to the Reporting Person pursuant to the Issuer's 2015 Incentive Plan. Read SEC document |
| May 16, 2023 Filed May 18, 2023 20:14 UTC |
Drayton ClaudiaDirector
|
GrantCommon Stock | 18,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-030614 · doc4.xml · nonDerivative · entry 1 Drayton Claudia · CIK 0001629827 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,485 F1 · shares: Shares were awarded to the Reporting Person pursuant to the Issuer's 2015 Incentive Plan. Read SEC document |
| May 16, 2023 Filed May 18, 2023 20:11 UTC |
Clinton MalissiaDirector
|
GrantCommon Stock | 18,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-030608 · doc4.xml · nonDerivative · entry 1 Clinton Malissia · CIK 0001769602 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,470 F1 · shares: Shares were awarded to the Reporting Person pursuant to the Issuer's 2015 Incentive Plan. Read SEC document |
| May 11, 2023 Filed May 12, 2023 20:14 UTC |
GRAVES JEFFREY ADirector · President and CEO
|
Tax withholdingCommon Stock | 124,618 | $8.42 | $1,049,283.56 |
DisclosureSEC source: 0001209191-23-029025 · doc4.xml · nonDerivative · entry 2 GRAVES JEFFREY A · CIK 0001251036 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 798,187 F2 · shares: Represents shares withheld to satisfy tax withholding obligations with respect to the settlement of the PSU award. Read SEC document |
| May 11, 2023 Filed May 12, 2023 20:14 UTC |
GRAVES JEFFREY ADirector · President and CEO
|
GrantCommon Stock | 255,102 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-029025 · doc4.xml · nonDerivative · entry 1 GRAVES JEFFREY A · CIK 0001251036 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 922,805 F1 · shares: Represents settlement of a performance-based restricted stock unit ("PSU") award based on the maximum achievement of the performance metric over the three-year performance period ending on May 11, 2023. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 21:06 UTC |
ZUIKER JOSEPH R.EVP, Engineering & Operations
|
GrantCommon Stock | 44,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024703 · doc4.xml · nonDerivative · entry 1 ZUIKER JOSEPH R. · CIK 0001957687 · EVP, Engineering & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,997 F1 · shares: The Reporting Person has been awarded 44,820 shares of restricted stock under the Issuer's 2015 Incentive Plan. One-third of the total shares awarded vest on April 14, 2024, an additional one-third of the total shares awarded vest on April 14, 2025, and the remaining shares awarded vest on April 14, 2026, subject to continued employment. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 21:05 UTC |
Turner Michael LynnEVP & Chief Financial Officer
|
GrantCommon Stock | 74,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024700 · doc4.xml · nonDerivative · entry 1 Turner Michael Lynn · CIK 0001942135 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203,566 F1 · shares: The Reporting Person has been awarded 74,701 shares of restricted stock under the Issuer's 2015 Incentive Plan. One-third of the total shares awarded vest on April 14, 2024, an additional one-third of the total shares awarded vest on April 14, 2025, and the remaining shares awarded vest on April 14, 2026, subject to continued employment. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 21:05 UTC |
Puthenveetil RejiEVP, Industrial Solutions
|
GrantCommon Stock | 67,231 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024699 · doc4.xml · nonDerivative · entry 1 Puthenveetil Reji · CIK 0001826896 · EVP, Industrial Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,416 F1 · shares: The Reporting Person has been awarded 67,231 shares of restricted stock under the Issuer's 2015 Incentive Plan. One-third of the total shares awarded vest on April 14, 2024, an additional one-third of the total shares awarded vest on April 14, 2025, and the remaining shares awarded vest on April 14, 2026, subject to continued employment. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 21:03 UTC |
Nordstrom Phyllis BEVP & CHRO
|
GrantCommon Stock | 49,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024697 · doc4.xml · nonDerivative · entry 1 Nordstrom Phyllis B · CIK 0001879982 · EVP & CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,404 F1 · shares: The Reporting Person has been awarded 49,800 shares of restricted stock under the Issuer's 2015 Incentive Plan. One-third of the total shares awarded vest on April 14, 2024, an additional one-third of the total shares awarded vest on April 14, 2025, and the remaining shares awarded vest on April 14, 2026, subject to continued employment. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 21:02 UTC |
Johnson Andrew MartinEVP, Chief Legal Officer & Sec
|
GrantCommon Stock | 49,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024696 · doc4.xml · nonDerivative · entry 1 Johnson Andrew Martin · CIK 0001548887 · EVP, Chief Legal Officer & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 211,813 F1 · shares: The Reporting Person has been awarded 49,800 shares of restricted stock under the Issuer's 2015 Incentive Plan. One-third of the total shares awarded vest on April 14, 2024, an additional one-third of the total shares awarded vest on April 14, 2025, and the remaining shares awarded vest on April 14, 2026, subject to continued employment. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 21:01 UTC |
HULL CHARLES WDirector · EVP & CTO (Regenerative Med)
|
GrantCommon Stock | 29,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024693 · doc4.xml · nonDerivative · entry 1 HULL CHARLES W · CIK 0001105964 · Director · EVP & CTO (Regenerative Med) 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,193 F1 · shares: The Reporting Person has been awarded 29,880 shares of restricted stock under the Issuer's 2015 Incentive Plan. One-third of the total shares awarded vest on April 14, 2024, an additional one-third of the total shares awarded vest on April 14, 2025, and the remaining shares awarded vest on April 14, 2026, subject to continued employment. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 21:00 UTC |
GRAVES JEFFREY ADirector · President and CEO
|
GrantCommon Stock | 189,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024687 · doc4.xml · nonDerivative · entry 1 GRAVES JEFFREY A · CIK 0001251036 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 667,703 F1 · shares: The Reporting Person has been awarded 189,243 shares of restricted stock under the Issuer's 2015 Incentive Plan. One-third of the total shares awarded vest on April 14, 2024, an additional one-third of the total shares awarded vest on April 14, 2025, and the remaining shares awarded vest on April 14, 2026, subject to continued employment. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:59 UTC |
Ellis MennoEVP, Healthcare Solutions
|
GrantCommon Stock | 67,231 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024686 · doc4.xml · nonDerivative · entry 1 Ellis Menno · CIK 0001818316 · EVP, Healthcare Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,425 F1 · shares: The Reporting Person has been awarded 67,231 shares of restricted stock under the Issuer's 2015 Incentive Plan. One-third of the total shares awarded vest on April 14, 2024, an additional one-third of the total shares awarded vest on April 14, 2025, and the remaining shares awarded vest on April 14, 2026, subject to continued employment. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 21:16 UTC |
Puthenveetil RejiEVP, Industrial Solutions
|
Tax withholdingCommon Stock | 5,965 | $10.17 | $60,664.05 |
DisclosureSEC source: 0001209191-23-019378 · doc4.xml · nonDerivative · entry 1 Puthenveetil Reji · CIK 0001826896 · EVP, Industrial Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,185 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on March 15, 2022. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 21:15 UTC |
Nordstrom Phyllis BEVP & CHRO
|
Tax withholdingCommon Stock | 4,074 | $10.17 | $41,432.58 |
DisclosureSEC source: 0001209191-23-019377 · doc4.xml · nonDerivative · entry 1 Nordstrom Phyllis B · CIK 0001879982 · EVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,604 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on March 15, 2022. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 21:14 UTC |
Johnson Andrew MartinEVP, Chief Legal Officer & Sec
|
Tax withholdingCommon Stock | 4,204 | $10.17 | $42,754.68 |
DisclosureSEC source: 0001209191-23-019376 · doc4.xml · nonDerivative · entry 1 Johnson Andrew Martin · CIK 0001548887 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,013 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on March 15, 2022. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 21:12 UTC |
HULL CHARLES WDirector · EVP & CTO (Regenerative Med)
|
Tax withholdingCommon Stock | 2,091 | $10.17 | $21,265.47 |
DisclosureSEC source: 0001209191-23-019373 · doc4.xml · nonDerivative · entry 1 HULL CHARLES W · CIK 0001105964 · Director · EVP & CTO (Regenerative Med) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,313 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on March 15, 2022. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 21:11 UTC |
GRAVES JEFFREY ADirector · President and CEO
|
Tax withholdingCommon Stock | 18,706 | $10.17 | $190,240.02 |
DisclosureSEC source: 0001209191-23-019370 · doc4.xml · nonDerivative · entry 1 GRAVES JEFFREY A · CIK 0001251036 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 478,460 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on March 15, 2022. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 21:10 UTC |
Ellis MennoEVP, Healthcare Solutions
|
Tax withholdingCommon Stock | 5,354 | $10.17 | $54,450.18 |
DisclosureSEC source: 0001209191-23-019366 · doc4.xml · nonDerivative · entry 1 Ellis Menno · CIK 0001818316 · EVP, Healthcare Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,194 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on March 15, 2022. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 23:45 UTC |
HULL CHARLES WDirector · EVP & CTO (Regenerative Med)
|
Tax withholdingCommon Stock | 3,287 | $11.66 | $38,326.42 |
DisclosureSEC source: 0001209191-23-010882 · doc4.xml · nonDerivative · entry 1 HULL CHARLES W · CIK 0001105964 · Director · EVP & CTO (Regenerative Med) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,404 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on February 18, 2020. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 23:46 UTC |
Johnson Andrew MartinEVP, Chief Legal Officer & Sec
|
Tax withholdingCommon Stock | 4,718 | $11.66 | $55,011.88 |
DisclosureSEC source: 0001209191-23-010883 · doc4.xml · nonDerivative · entry 1 Johnson Andrew Martin · CIK 0001548887 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,217 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on February 18, 2020. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 23:43 UTC |
Ellis MennoEVP, Healthcare Solutions
|
Tax withholdingCommon Stock | 3,579 | $11.66 | $41,731.14 |
DisclosureSEC source: 0001209191-23-010879 · doc4.xml · nonDerivative · entry 1 Ellis Menno · CIK 0001818316 · EVP, Healthcare Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,548 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on February 18, 2020. Read SEC document |
| January 12, 2023 Filed Jan 14, 2023 00:35 UTC |
Johnson Andrew MartinEVP, Chief Legal Officer & Sec
|
Tax withholdingCommon Stock | 5,628 | $9.00 | $50,652.00 |
DisclosureSEC source: 0001209191-23-003378 · doc4.xml · nonDerivative · entry 1 Johnson Andrew Martin · CIK 0001548887 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,935 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on January 12, 2021. Read SEC document |
| January 12, 2023 Filed Jan 14, 2023 00:36 UTC |
Puthenveetil RejiEVP, Industrial Solutions
|
Tax withholdingCommon Stock | 5,852 | $9.00 | $52,668.00 |
DisclosureSEC source: 0001209191-23-003379 · doc4.xml · nonDerivative · entry 1 Puthenveetil Reji · CIK 0001826896 · EVP, Industrial Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,150 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on January 12, 2021. Read SEC document |
| January 12, 2023 Filed Jan 14, 2023 00:32 UTC |
GRAVES JEFFREY ADirector · President and CEO
|
Tax withholdingCommon Stock | 18,300 | $9.00 | $164,700.00 |
DisclosureSEC source: 0001209191-23-003376 · doc4.xml · nonDerivative · entry 1 GRAVES JEFFREY A · CIK 0001251036 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 497,166 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on January 12, 2021. Read SEC document |
| January 12, 2023 Filed Jan 14, 2023 00:33 UTC |
HULL CHARLES WDirector · EVP & CTO (Regenerative Med)
|
Tax withholdingCommon Stock | 3,491 | $9.00 | $31,419.00 |
DisclosureSEC source: 0001209191-23-003377 · doc4.xml · nonDerivative · entry 1 HULL CHARLES W · CIK 0001105964 · Director · EVP & CTO (Regenerative Med) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,691 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on January 12, 2021. Read SEC document |
| January 12, 2023 Filed Jan 14, 2023 00:29 UTC |
Ellis MennoEVP, Healthcare Solutions
|
Tax withholdingCommon Stock | 5,724 | $9.00 | $51,516.00 |
DisclosureSEC source: 0001209191-23-003375 · doc4.xml · nonDerivative · entry 1 Ellis Menno · CIK 0001818316 · EVP, Healthcare Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,127 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on January 12, 2021. Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 22:02 UTC |
GRAVES JEFFREY ADirector · President and CEO
|
Tax withholdingCommon Stock | 53,715 | $7.49 | $402,325.35 |
DisclosureSEC source: 0001209191-23-001055 · doc4.xml · nonDerivative · entry 1 GRAVES JEFFREY A · CIK 0001251036 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 515,466 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock units originally made on May 26, 2020. Read SEC document |
| December 13, 2022 Filed Dec 14, 2022 21:18 UTC |
Johnson Andrew MartinEVP, Chief Legal Officer & Sec
|
Tax withholdingCommon Stock | 1,871 | $9.21 | $17,231.91 |
DisclosureSEC source: 0001209191-22-061192 · doc4.xml · nonDerivative · entry 1 Johnson Andrew Martin · CIK 0001548887 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,563 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on December 13, 2019. Read SEC document |
| December 13, 2022 Filed Dec 14, 2022 21:17 UTC |
HULL CHARLES WDirector · EVP & CTO (Regenerative Med)
|
Tax withholdingCommon Stock | 2,452 | $9.21 | $22,582.92 |
DisclosureSEC source: 0001209191-22-061190 · doc4.xml · nonDerivative · entry 1 HULL CHARLES W · CIK 0001105964 · Director · EVP & CTO (Regenerative Med) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,182 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on December 13, 2019. Read SEC document |
| December 13, 2022 Filed Dec 14, 2022 21:16 UTC |
Ellis MennoEVP, Healthcare Solutions
|
Tax withholdingCommon Stock | 1,639 | $9.21 | $15,095.19 |
DisclosureSEC source: 0001209191-22-061189 · doc4.xml · nonDerivative · entry 1 Ellis Menno · CIK 0001818316 · EVP, Healthcare Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,851 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on December 13, 2019. Read SEC document |
| December 12, 2022 Filed Dec 14, 2022 21:20 UTC |
ZUIKER JOSEPH R.EVP, Engineering & Operations
|
GrantCommon Stock | 51,177 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-061195 · doc4.xml · nonDerivative · entry 1 ZUIKER JOSEPH R. · CIK 0001957687 · EVP, Engineering & Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,177 F1 · shares: The Reporting Person has been awarded 51,177 shares of restricted stock under the Issuer's 2015 Incentive Plan. One-third of total shares awarded will vest on December 12, 2023, an additional one-third of the total shares will vest on December 12, 2024, and the remining shares awarded will vest on December 12, 2025. Read SEC document |
| December 09, 2022 Filed Dec 9, 2022 22:01 UTC |
Johnson Andrew MartinEVP, Chief Legal Officer & Sec
|
SaleCommon Stock | 7,787 | $9.39 | $73,119.93 |
DisclosureSEC source: 0001209191-22-060520 · doc4.xml · nonDerivative · entry 1 Johnson Andrew Martin · CIK 0001548887 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,434 Read SEC document |
| December 05, 2022 Filed Dec 9, 2022 22:46 UTC |
Leigh David KEVP & CTO (Additive Mfg)
|
Tax withholdingCommon Stock | 3,316 | $9.74 | $32,297.84 |
DisclosureSEC source: 0001209191-22-060568 · doc4.xml · nonDerivative · entry 1 Leigh David K · CIK 0001870051 · EVP & CTO (Additive Mfg) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,977 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of the remaining shares outstanding of a grant of restricted stock issued on June 28, 2021 in connection with the Reporting Person's separation from employment pursuant to the terms of his Executive Employment Agreement. F2 · balance_after: Other than reported herein, all other unvested equity held by the Reporting Person was forfeited upon his separation as an employee. Read SEC document |
| December 02, 2022 Filed Dec 14, 2022 21:19 UTC |
Nordstrom Phyllis BEVP & CHRO
|
GrantCommon Stock | 10,672 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-061193 · doc4.xml · nonDerivative · entry 1 Nordstrom Phyllis B · CIK 0001879982 · EVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,100 F1 · shares: The Reporting Person has been awarded 10,672 shares of restricted stock under the Issuer's 2015 Incentive Plan. One-third of the total shares awarded vest on December 2, 2023, an additional one-third of the total shares awarded vest on December 2, 2024, and the remaining shares awarded vest on December 2, 2025. Read SEC document |
| November 28, 2022 Filed Nov 29, 2022 21:34 UTC |
GRAVES JEFFREY ADirector · President and CEO
|
PurchaseCommon Stock | 10,000 | $9.50 | $95,000.00 |
DisclosureSEC source: 0001209191-22-058948 · doc4.xml · nonDerivative · entry 2 GRAVES JEFFREY A · CIK 0001251036 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 569,181 Read SEC document |
| November 25, 2022 Filed Nov 29, 2022 21:34 UTC |
GRAVES JEFFREY ADirector · President and CEO
|
PurchaseCommon Stock | 10,000 | $9.70 | $97,000.00 |
DisclosureSEC source: 0001209191-22-058948 · doc4.xml · nonDerivative · entry 1 GRAVES JEFFREY A · CIK 0001251036 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 559,181 Read SEC document |
| October 01, 2022 Filed Oct 4, 2022 20:15 UTC |
Puthenveetil RejiEVP, Industrial Solutions
|
Tax withholdingCommon Stock | 12,470 | $8.53 | $106,369.10 |
DisclosureSEC source: 0001209191-22-052205 · doc4.xml · nonDerivative · entry 1 Puthenveetil Reji · CIK 0001826896 · EVP, Industrial Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,002 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on October 5, 2020. Read SEC document |
| September 09, 2022 Filed Sep 9, 2022 23:43 UTC |
Johnson Andrew MartinEVP, Chief Legal Officer & Sec
|
SaleCommon Stock | 6,767 | $10.06 | $68,076.02 |
DisclosureSEC source: 0001209191-22-049364 · doc4.xml · nonDerivative · entry 1 Johnson Andrew Martin · CIK 0001548887 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,221 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.06 to $10.061, inclusive. The reporting person undertakes to provide to 3D Systems Corporation, any security holder of 3D Systems Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 of this Form 4. Read SEC document |
| August 31, 2022 Filed Sep 1, 2022 20:41 UTC |
Pensky Wayne CInterim CFO
|
GrantCommon Stock | 8,849 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-048254 · doc4.xml · nonDerivative · entry 1 Pensky Wayne C · CIK 0001396157 · Interim CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,849 F1 · shares: The Reporting Person has been awarded 8,849 shares of restricted stock under the Issuer's 2015 Incentive Plan. These shares of restricted stock vest immediately. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.